We are live on ! Find out more
AVIR icon

Atea Pharmaceuticals
AVIR

69 hedge funds and large institutions have $2.07B invested in Atea Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60.41% more ownership

Funds ownership: 0% → 60.41% (+60%)

Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
1.22%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.16%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$208M
2
CAM
Cormorant Asset Management
Massachusetts
+$207M
3
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$181M
4
RCM
RA Capital Management
Massachusetts
+$173M
5
PA
Perceptive Advisors
New York
+$100M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$472K +$364K +11,300 New
Deutsche Bank
52
Deutsche Bank
Germany
$443K +$341K +10,594 New
UBS Group
53
UBS Group
Switzerland
$442K +$341K +10,570 New
Wells Fargo
54
Wells Fargo
California
$316K +$244K +7,562 New
BI
55
Bramshill Investments
Florida
$310K +$239K +7,416 New
MIM
56
MetLife Investment Management
New Jersey
$290K +$224K +6,936 New
William Blair & Company
57
William Blair & Company
Illinois
$223K +$172K +5,330 New
PNC Financial Services Group
58
PNC Financial Services Group
Pennsylvania
$209K +$161K +5,000 New
MLICM
59
Metropolitan Life Insurance Company (MetLife)
New York
$203K +$156K +4,847 New
VOYA Investment Management
60
VOYA Investment Management
Georgia
$202K +$156K +4,828 New
SO
61
STRS Ohio
Ohio
$146K +$113K +3,500 New
Citigroup
62
Citigroup
New York
$115K +$88.5K +2,747 New
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
$106K +$72.8K +2,260 New
AIP
64
Ameritas Investment Partners
Nebraska
$51K +$39.2K +1,215 New
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
$15K +$11.7K +362 New
TRCT
66
Tower Research Capital (TRC)
New York
$14K +$10.7K +332 New
APA
67
American Portfolios Advisors
New York
$8.56K +$6.61K +205 New
IAIM
68
International Assets Investment Management
Florida
$4K +$3.22K +100 New
AIG
69
American International Group
New York
$352 +$272K +8,429 New
1 2
3

AVIR Hedge Fund Activity: Q4 2020 in Review

69 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Atea Pharmaceuticals (AVIR) for Q4 2020, worth a combined $2.07B.

Buyers outnumbered sellers: 69 funds opened new AVIR positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $208M.

  • 69 institutional investors held Atea Pharmaceuticals (AVIR) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $2.07B of Atea Pharmaceuticals stock for Q4 2020.
  • 69 funds opened new Atea Pharmaceuticals positions in Q4 2020 and 0 closed out, a net change of +69 holders.
  • The largest Atea Pharmaceuticals buyer in Q4 2020 was Fidelity Investments, an estimated $208M added.

Based on aggregated 13F filings for Q4 2020.